Cutler Group LP Beyond Air, Inc. Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022
SELL
$7.42 - $11.39 $25,228 - $38,726
-3,400 Reduced 66.67%
1,700 $0
Q2 2022

Aug 04, 2022
BUY
$4.96 - $7.83 $16,864 - $26,622
3,400 Added 200.0%
5,100 $5,000
Q1 2022

Apr 14, 2022
SELL
$6.33 - $9.53 $30,384 - $45,744
-4,800 Reduced 73.85%
1,700 $0
Q4 2021

Jan 18, 2022
BUY
$8.44 - $15.61 $37,136 - $68,684
4,400 Added 209.52%
6,500 $1,000
Q3 2021

Oct 26, 2021
BUY
$5.9 - $12.54 $5,310 - $11,286
900 Added 75.0%
2,100 $0
Q2 2021

Jul 19, 2021
BUY
$4.72 - $7.15 $5,664 - $8,580
1,200 New
1,200 $1,000

Others Institutions Holding XAIR

# of Institutions
64
Shares Held
11.1M
Call Options Held
54.4K
Put Options Held
7K
View Full List

About Beyond Air, Inc.

XAIR Quotes by TradingView
  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $17M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email